Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics - 17/08/25
, M. Manuela Gaspar a, b, ⁎
, Catarina Pinto Reis a, b, ⁎ 
Abstract |
Gold nanoparticle (AuNP)-mediated photothermal therapy (PTT) has emerged as a promising approach for cancer treatment, offering high precision, minimal invasiveness, and selective tumor ablation through localized hyperthermia. This review explores the fundamental principles of AuNP-mediated PTT, including the design of AuNPs, synthesis strategies, and surface modifications that enhance their biocompatibility and targeting efficiency. Additionally, the integration of AuNPs with other therapeutic modalities is also discussed, such as chemotherapy, radiotherapy, and immunotherapy, to achieve synergistic treatment outcomes. The theragnostic potential of AuNPs, combining diagnostic imaging with therapeutic applications, is also highlighted, emphasizing their role in personalized medicine. But, despite significant advancements, challenges such as biodistribution, long-term safety, and regulatory approval remain key barriers to clinical translation. Ongoing research is expected to refine AuNP-based PTT, paving the way for its widespread clinical application in cancer treatment.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Review of gold nanoparticle (AuNP)-mediated photothermal therapy (PTT) for cancer. |
• | Synergistic integration of AuNP-based PTT with chemotherapy, radiotherapy and immunotherapy. |
• | Theragnostic potential of AuNPs, emphasizing their dual role in targeted therapy and diagnostic for personalized medicine. |
• | Biodistribution, long-term safety, and regulatory hurdles hindering clinical application. |
• | Future perspectives and strategies to optimize AuNP-based PTT and accelerate its clinical implementation. |
Keywords : Gold nanoparticles, Photothermal therapy, Cancer, Novel therapies, Hyperthermia, Photothermal agents
Plan
Vol 190
Article 118399- septembre 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
